The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro (Q40637109)
scientific article published on 7 August 2003
Language:
(P31) (Q13442814)
(P304) 5105-5117
(P407) (Q1860)
(P433) 11
(P478) 144
(P577) Thursday, August 7, 2003
(P1433) (Q3054009)
(P1476) "The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro" (language: en)
(P2093) J M W Gee
M E Harper
I R Hutcheson
T A Madden
D Barrow
J M Knowlden
R A McClelland
N Jordan
A E Wakeling
R I Nicholson
other details
description scientific article published on 7 August 2003

External Links